The abstract was submitted to the European Academy of Neurology for presentation at their annual meeting. It gives an overview of a recent CNS study that investigated the occurrence of alpha-synuclein in ALS spinal fluid.
The presentation will be given by Dr. Smith on June 27th, 2022 in Vienna, Austria. More details can be found here.
The session entitled Guamanian ALS Parkinson's Dementia Complex was co-chaired by Dr. Richard Smith and his colleague Dr. Jeffery Kelly, co-chairman of the Department of Molecular Medicine at Scripps Research.
The following presentations were included in this session:
The Vanishing Incidence of ALS-PD on Guam: Current Implications (Ralph Garruto, PhD, Binghamton University)
From Guam to ALS Therapy (Paul Cox, PhD, Director of the Institute for Ethnomedicine)
The Emerging Role of Misfolded Synuclein Prions in Initiation and Progression of Neurodegenerative Diseases (Russ Lebovitz, MD, PhD, CEO of Amprion Inc.)
Click here to view the full Summit schedule.
Neurotherapeutics in the Era of Translational Medicine Speaker: Richard A. Smith, M.D.
Director, Center for Neurologic Study
La Jolla, California
Friday, November 12, 12:00 p.m. to 1:00 p.m. CDT
Event Link: https://houstonmethodist.webex.com/houstonmethodist/j.php?MTID=macfa79ed611475ed2194b23edfc383d9
Access code: 2530 124 9830
Meeting password: MaFEGCwm653